Top news of the week: 30.03.2022.
Startups
In Defense Of Early Stage Biotech IPOs
There’s “just too many early stage companies going public”, or so goes one of the most common lamentations about the current state of the biotech market. I’ve read a good deal of venting ...
Biotech Startup Fundraising Has Been Resilient, But Investors Are Selective
Venture-capital investment in the biotechnology sector has proved to be resilient so far this year, despite stock-market turbulence and the slower pace of initial public offerings.
DNA Synthesis Goes Green
DNA enzymatic synthesis represents an enormously valuable next step in harnessing the power of DNA replication and our ability to use it for developing cutting-edge, biotechnology solutions.
Massachusetts Life Sciences Center announces Mission BioCapital as newest sponsor for initiative to support female entrepreneurs
Mission BioCapital to support female entrepreneurs with a $100K Mission BioCapital Award in the 2022 MassNextGen program round. Today, the Massachusetts Life Sciences Center (MLSC) ...
Creating the Next Groundbreaking Company with Geoffrey von Maltzahn, Biological Engineer and Serial Entrepreneur
Listen to this episode from Forge Ahead on Spotify. Engineering is in Geoffrey’s blood. He’s a fourth-generation engineer who fell in love with the possibilities of the biotechnology ...
Celebrating Women in Life Science Part I: Business
On International Women’s Day we like to highlight some of the many inspiring women in life science that we have had the opportunity to meet and interview. Within life science business ...
Boston tops San Francisco Bay Area to lead U.S. life-sciences lab construction
The Boston area, with a talent pool fed by dozens of colleges and universities, is pulling in more venture capital money, bolstering its ecosystem of big pharmaceutical companies, hospitals ...
Pharma TV Ads And R&D Funding
Nevertheless, the perception remains that extraordinary amounts of money are spent on TV ads at the expense of R&D. The data show that this isn’t the case.